This PDF is the current document as it appeared on Public Inspection on 07/29/2013 at 08:45 am.
Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is announcing Start Printed Page 45930that a collection of information entitled “Guidance on Reagents for Detection of Specific Novel Influenza A Viruses” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Daniel Gittleson, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, 301-796-5156, Daniel.Gittleson@fda.hhs.gov.End Further Info End Preamble Start Supplemental Information
On March 20, 2013, the Agency submitted a proposed collection of information entitled “Guidance on Reagents for Detection of Specific Novel Influenza A Viruses” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0584. The approval expires on April 30, 2016. A copy of the supporting statement for this information collection is available on the Internet at http://www.reginfo.gov/public/do/PRAMain.Start Signature
Dated: July 24, 2013.
Assistant Commissioner for Policy.
[FR Doc. 2013-18227 Filed 7-29-13; 8:45 am]
BILLING CODE 4160-01-P